Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
An open-label phase I study to evaluate the safety of the HIV-1 vaccine MVA-B in chronic HIV-1 infected patients successfully treated with HAART

Proposed period of release:
01/12/2006 to 31/12/2008

Name of the Institute(s) or Company(ies)
Academic Medical Center, Amsterdam;

3. Is the same GMO release planned elsewhere in the Community?
Germany; France;

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
MVA-BorthopoxvirusvacciniaModified Virus Ankara

Final report

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known